Work

Development and Validation of a Magnetic Microsphere-Assisted Fluorescence Assay for LL37 Detection Based on a Nucleic Acid Aptamer

Year: 2026
Type: article
Abstract: Antimicrobial peptide LL37, a cationic small peptide composed of 37 amino acids, serves as a potential biomarker for autoimmune diseases. However, its quantitative detection remains challenging due to its low molecular weight and poor immunogenicity. Therefore available methods of LL37 detection are often complex, time-consuming, and expensive. In this study, a magnetic microsphere fluorescence assay based on a nucleic acid aptamer was developed for LL37 quantification. The aptamer (Apt-01) was labeled with Cy3 and biotin at the end of 3′ and 5′, respectively, and a BHQ2-labeled complementary DNA served as a quencher. Upon target binding, a dose-dependent fluorescence recovery consistent with cDNA displacement by LL37 was observed. Under optimized aptamer and cDNA concentrations, as well as incubation time, the assay exhibited a favorable linear range of 0.5–20 ng/mL (R2 = 0.9941) with a limit of detection of 0.089 ng/mL. Spike recovery rates ranged from 85% to 116% with relative standard deviations below 10%. Moreover, the detection results of LL37 showed good concordance with those of a commercial ELISA kit, with deviations of RSD in ±3.0%. In conclusion, the aptamer-based microsphere fluorescence assay offers a practical alternative to antibody dependent approaches for LL37 detection. This platform also holds great potential for broad application in autoimmune disease diagnostics.
Source: Biosensors
Language: English
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7236712509
FWCI:
Cites: 30
Cited by:
Related to: 10